Member Info for DeBull

I think PYC tweeted about doseme in late March ( as per Ralph post ) and in mid June the doseme update RNS arrived.

Laura, this is the post, its actually a repost or retweet in old money, so not technically a tweet as i first said.

https://x.com/sheffielduni/status/1820399409898586226

"A new form of immunotherapy could give new hope for prostate cancer.

@clancie55 research, funded by

@ProstateUKProfs, shows that using innovative nanoparticles can delay resistance to hormone therapy and help men with prostate cancer live longer."

I believe that Sheffield Uni got substantial funding from Yorkshire cancer research, hence why they have quite a few irons in the cancer fights fire. Be it the above or the fruit fly angle which PYC have collab'd on.

Notice that PYC tweeted about the Shef uni prostate cancer info that was posted yesterday by Laura.

Good volume today to.

I believe this is the article from the JIC?

https://jitc.bmj.com/content/12/7/e009368

There are a lot of names on this report, including Johann de Bono who is one of the top bods at ICR.

Dr Kyra Campbell is the lead name with PYC collab.

Only own PYC

Allowed to moan as the price is rubbish right now. I am positive when the information relayed is good. Where are these snide remarks?

201 is a long shot for PYC at this moment to get £ in to their coffers. Fact.

Very optimistic about Doseme.

Other posters have felt the wrath for being negative, yet when a positive comment comes along, back into the fold these same posters come.

Their accomplishments with Bicycle / Cellcentric are to be applauded and have been.

Yet any person who dares to go against the grain either gets filtered or very odd.

Whats the issue ? So what if a ticker is mentioned and a reply to the optimism is made. Someone writes posts and a reply is not forthcoming? What this 3 months malarkey that has been mentioned?

It would be good to make a poll here a to what LTH PYC holders really think of VAL201? We all know what PYC could get if VAL201 come to fruition? However, at this moment in time, and for the foreseeable future, 201 is beached.

Let me guess, i know whats coming next.......

Laura, love the optimism, and yes its great that VAL has a new CEO.

However, i would temper that optimism that their new CEO will have many things to address, as well as the the VAL201 debacle. I would imagine it could take weeks if not months for him to reorganise the decks over there. Who knows where his priorities lie with VAL201?

Hiya Trench, yes this was highlighted some time ago, but thanks for highlighting it again.

Https://www.clinicaltrialsarena.com/news/partner-relationships-drive-optimised-oncology-clinical-trials/?cf-view

interesting last sentence.

"Despite the caution, Liang finds that the industry is “reawakening” with select IPO windows opening, biotechs entering mergers and acquisition deals, and a few companies raising larger financing rounds to secure capital. But in the current environment trends point to waning investor interest in oncology, she added."

"identify one or more centres in the US, currently served by DoseMe, that have historical patient data that could be used to further develop Physiomics’ dosing software "

This is a list from Doseme where this historical patient data could be taken from?

https://doseme-rx.com/en-gb/news-media/articles

Https://www.tmcnet.com/usubmit/-doseme-expands-licensing-agreement-with-dotlib-/2024/07/23/10046419.htm

Https://x.com/CellCentric/status/1816148448418357358

They have received $35m

I posted a reply to Aim123 this morning, about trade volumes and its gone from this site?

They said a trade of 60+m had gone through? I replied saying that would have been 25% of the total amount of shares of the company. Where did they get that info from, or was it a typo? Why was post removed?

Whats was all these tiny & repeated trades again?

Maybe these small items as you put them Laura are important to some people? Maybe these small things all add up and if they dont, no matter on what the numbers say, the company may not be invest-able to individuals?

Looks like Ben and Gary or anyone else may have been diluted under 3%, but we may never know now?

The website errors are just rubbish, you'd expect these to be sorted asap, especially if hey have been highlighted? If the company do not do anything, would it be the NOMAD to go to to exert pressure on the board to address these failings.

As Trench says, strange how they announce these details a fortnight or so early, and also shows no new entities have come on board with substantial purchases during the raise.

The 5M trade looks like a sell?

Approx 4M bought in the space of a few minutes.

Laura, are you saying the 8M trade is buy? the buy price was 0.7 at the time and 0.6 to sell? approx £56k

8+m trade on 4th July at 1715 at 0.6

Good spot Laura.

Like Trench, i only know of Merck deal that could constituent a multi year deal?

All other deals announced in the last few years are for 3,6,9 months.